SAN DIEGO--(BUSINESS WIRE)--Ignyta, Inc. (Nasdaq: RXDX), a precision oncology biotechnology company, announced today that its management will be making company presentations at the following investor conferences in December 2014:
- The Piper Jaffray 26th Annual Healthcare Conference at the Palace Hotel in New York, NY on December 2, 2014 at 9:30 a.m. Eastern time (presentation by Jonathan Lim, M.D., the company’s President and CEO); and
- The Oppenheimer & Co. 25th Annual Healthcare Conference at the Crowne Plaza Hotel in New York, NY on December 10, 2014 at 8:00 a.m. Eastern time (presentation by Jacob Chacko, M.D., the company’s CFO).
A webcast of each presentation will be available during the event in the Investors section of the company's website at http://investor.ignyta.com, and will be archived and available at that site for 14 days.
About Ignyta, Inc.
Ignyta, Inc., located in San Diego, California, is a precision oncology biotechnology company pursuing an integrated therapeutic (Rx) and companion diagnostic (Dx) strategy for treating cancer patients. The company’s goal with this Rx/Dx approach is to discover, develop and commercialize new drugs that target activated cancer genes and pathways for the customized treatment of cancer. It aims to achieve this goal by pairing each of its product candidates with biomarker-based companion diagnostics that are designed to identify, at the molecular level, the patients who are most likely to benefit from the precisely targeted drugs the company develops. For more information, please visit: www.ignyta.com.